Acute GVH Disease

9 registered clinical trials studyying Acute GVH Disease.

Status	Trial	Sponsor	Phase
Completed	MTX and Steroid as First-line Therapy for aGVHD NCT04960644	Peking University People's Hospital	Phase 3
Unknown	MTX and Steroid for aGVHD Treatment NCT04677868	Peking University People's Hospital	Phase 2
Completed	Skin Disease and Pulmonary Mortality After Transplantation NCT03320928	Karolinska University Hospital	—
Withdrawn	MicroRNAs as Diagnostic and Predictive Biomarkers for Acute Graft Versus Host Disease NCT02917148	Northwell Health	—
Completed	Gut Decontamination In Pediatric Allogeneic Hematopoietic NCT02641236	Dana-Farber Cancer Institute	Phase 2
Unknown	Biomarkers for Acute Graft-versus-host Disease NCT02254798	Assistance Publique - Hôpitaux de Paris	—
Unknown	Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease NCT01754454	Affiliated Hospital to Academy of Military Medical Sciences	Phase 1 / Phase 2
Unknown	Mesenchymal Stromal Cells for Acute Graft Versus Host Disease NCT01589549	R.P.Herrmann	Phase 2
Terminated	Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease NCT01485055	Nationwide Children's Hospital	Phase 2